The Director for Radiation Safety (the Director) intends to review the Code of Practice for Sealed Radioactive Material: ORS C12 2020 (ORS C12 2020). The review will be conducted in accordance with ...

In September 2024, funding was annouced for a Child and Youth Mental Health Study. The information from this study will support more effective decisions and planning, including a needs-based ...

Who is eligible To be eligible for transitional access, patients must either: be receiving private treatment with the cancer medicine at the time Pharmac begins its public funding; or start treatment ...

Starting from 1 July 2025, when a cancer medicine starts to be funded by Pharmac, patients in private facilities will be able to continue their treatment with publicly funded medicines in the same ...

General practitioners (GPs) and nurse practitioners will be able to start medical treatment for adults with ADHD, following decisions by Medsafe and Pharmac.

Trends in daily smoking and daily vaping vary by ethnic group Daily smoking has declined in all ethnic groups from 2011/12 to 2023/24, although trends have been more variable in Asian and Pacific ...

Our climate is changing. These changes are affecting what we value most in our lives, including our health and wellbeing. This first Health National Adaptation Plan (HNAP) is an important step towards ...

The Government is reviewing health workforce regulation to improve New Zealanders’ timely, quality access to healthcare. We have an opportunity to put patients at the centre, modernise and streamline ...

The consultation on safety measures for the use of puberty blockers in young people with gender-related health needs closed on 20 January 2025. We will now consider submissions.BackgroundThe ...

This literature review summarises the latest national and international evidence of the safety and long-term impacts of puberty blockers on adolescents. It is accompanied by the Ministry’s position ...

This position statement accompanies the release of an evidence brief which examines the safety and long-term impacts of puberty blockers when used in the context of gender-affirming care. This ...

In February 2024, the High Court directed the Director-General of Health to assess whether each of the 14 directions to fluoridate one or more water supplies made in 2022 were, in terms of section 5 ...